Compare VTEX & PRME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VTEX | PRME |
|---|---|---|
| Founded | 1999 | 2019 |
| Country | Cayman Islands | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Medicinal Chemicals and Botanical Products |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 752.7M | 666.1M |
| IPO Year | 2019 | 2022 |
| Metric | VTEX | PRME |
|---|---|---|
| Price | $3.92 | $3.54 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 6 | 6 |
| Target Price | $5.97 | ★ $7.56 |
| AVG Volume (30 Days) | 1.0M | ★ 1.7M |
| Earning Date | 05-07-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 18.18 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $4,632,000.00 |
| Revenue This Year | $12.78 | $7.06 |
| Revenue Next Year | $9.63 | $47.01 |
| P/E Ratio | $43.33 | ★ N/A |
| Revenue Growth | N/A | ★ 55.28 |
| 52 Week Low | $2.84 | $1.11 |
| 52 Week High | $6.82 | $6.94 |
| Indicator | VTEX | PRME |
|---|---|---|
| Relative Strength Index (RSI) | 46.90 | 45.49 |
| Support Level | $3.92 | $3.17 |
| Resistance Level | $4.21 | $3.94 |
| Average True Range (ATR) | 0.18 | 0.22 |
| MACD | -0.04 | -0.00 |
| Stochastic Oscillator | 16.15 | 36.84 |
Vtex provides a software-as-a-service digital commerce platform for enterprise brands and retailers. Its platform enables customers to execute their commerce plan, including building online stores, integrating and managing orders across channels, and creating marketplaces to sell products from third-party vendors. The VTEX platform is designed to be composable and complete, enabling its customers to seamlessly implement, optimize, test, and expand both B2C and B2B digital experiences. It generates maximum revenues from Brazil followed by Latin America and the rest of the world.
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.